Home > Insider Trading > Filing (0001209191-17-031678)

Filing Details

Accession Number:: 0001209191-17-031678
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-05-11 20:34:52
Reporting Period:: 2017-05-09

Filing Date:: 2017-05-11
Accepted Time:: 2017-05-11 20:34:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1180262	Herbalife Ltd.	HLF	Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1513887	Ibelis Fleming	800 W. Olympic Blvd., Suite 406 Los Angeles CA 90015	Svp/Managing Dir North America	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-05-09	4,874	$22.94	4,874	No	4	M	Direct
Common Stock	Disposition	2017-05-09	1,536	$72.81	3,338	No	4	D	Direct
Common Stock	Disposition	2017-05-09	1,255	$72.81	2,083	No	4	F	Direct
Common Stock	Acquisiton	2017-05-09	8,000	$32.67	10,083	No	4	M	Direct
Common Stock	Disposition	2017-05-09	3,590	$72.81	6,493	No	4	D	Direct
Common Stock	Disposition	2017-05-09	1,667	$72.81	4,826	No	4	F	Direct
Common Stock	Acquisiton	2017-05-09	13,050	$30.44	17,876	No	4	M	Direct
Common Stock	Disposition	2017-05-09	5,456	$72.81	12,420	No	4	D	Direct
Common Stock	Disposition	2017-05-09	3,964	$72.81	8,456	No	4	F	Direct
Common Stock	Disposition	2017-05-11	8,456	$71.54	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	D	Direct
No	4	F	Direct
No	4	M	Direct
No	4	D	Direct
No	4	F	Direct
No	4	M	Direct
No	4	D	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Appreciation Rights	Disposition	2017-05-09	4,874	$0.00	4,874	$22.94
Common Stock	Stock Appreciation Rights	Disposition	2017-05-09	8,000	$0.00	8,000	$32.67
Common Stock	Stock Appreciation Rights	Disposition	2017-05-09	13,050	$0.00	13,050	$30.44

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2013-05-07	2020-05-07	No	4	M	Direct
0	2014-01-31	2021-01-31	No	4	M	Direct
19,576	2017-03-02	2025-03-02	No	4	M	Direct

Footnotes

The reporting person received 2,083 shares of common stock upon the net exercise of the 4,874 stock appreciation rights ("SARs"). The reporting person forfeited 1,536 shares of common stock underlying the SARS in payment of the exercise price and 1,255 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.
The reporting person received 2,743 shares of common stock upon the net exercise of the 8,000 SARS. The reporting person forfeited 3,590 shares of common stock underlying the SARS in payment of the exercise price and 1,667 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.
The reporting person received 3,630 shares of common stock upon the net exercise of the 13,050 SARS. The reporting person forfeited 5,456 shares of common stock underlying the SARS in payment of the exercise price and 3,964 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.
This transaction was executed in multiple trades at prices ranging from $71.37 to $71.67. The price reported reflects the weighted average sale price of $71.5345. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction waseffected.
Consists of 32,626 stock appreciation rights granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested on March 2, 2016, 20% vested on March 2, 2017, and the remaining 60% will vest on March 2, 2018.